DOI: 10.1007/bf02253544. Chronic treatments with cholinoceptor drugs influence spatial learning in rats

Chronic treatments with cholinoceptor drugs influence spatial learning in rats

10.1007/bf02253544

Crossref journal-article

Springer Science and Business Media LLC

Psychopharmacology (297)

Bibliography

Abdulla, F. A., Calaminici, M.-R., Stephenson, J. D., & Sinden, J. D. (1993). Chronic treatments with cholinoceptor drugs influence spatial learning in rats. Psychopharmacology, 111(4), 508â511.

Authors 4

F. A. Abdulla (first)
M. -R. Calaminici (additional)
J. D. Stephenson (additional)
J. D. Sinden (additional)

References 30 Referenced 30

Abdulla FA, Calaminici M-R, Gray JA, Sinden JD, Stephenson JD (1992) Chronic hyoscine and oxotremorine treatment alter the sensitivity of rat frontal cortex pyramidal cells to acetylcholine and carbachol. Br J Pharmacol 106:39P
Beatty W, Butters N, Janowsky D (1986) Memory failure after scopolamine treatment: implications for cholinergic hypothesis of dementia. Behav Neural Biol 45:196–211 (10.1016/S0163-1047(86)90772-7) / Behav Neural Biol by W Beatty (1986)
Becker RE, Giacobini E (1988) Mechanisms of cholinesterase inhibition in senile dementia of Alzheimer type: clinical, pharmacological and therapeutic aspects. Drug Dev Res 12:163–195 (10.1002/ddr.430120302) / Drug Dev Res by RE Becker (1988)
Ben-Barak J, Gazit H, Silman I, Dudai Y (1981) In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands. Eur J Pharmacol 74:73–81 (10.1016/0014-2999(81)90325-3) / Eur J Pharmacol by J Ben-Barak (1981)
Brazell MP, Mitchell SN, Gray JA (1990) Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study. Neuropharmacology 30:823–833 (10.1016/0028-3908(91)90116-S) / Neuropharmacology by MP Brazell (1990)
Burešova O, Bolthius J, Bureš J (1986) Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial arm maze. Behav Neuroscience 100:476–482 (10.1037/0735-7044.100.4.476) / Behav Neuroscience by O Burešova (1986)
Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19:1–28 (10.1016/0306-4522(86)90002-3) / Neuroscience by D Collerton (1986)
Creese I, Sibley DR (1981) Receptor adaptations to centrally acting drugs. Annu Rev Pharmacol Toxicol 21:357–391 (10.1146/annurev.pa.21.040181.002041) / Annu Rev Pharmacol Toxicol by I Creese (1981)
Dunnett SB (1990) Neural transplantation in animal models of dementia. Eur J Neurosci 2:567–587 (10.1111/j.1460-9568.1990.tb00448.x) / Eur J Neurosci by SB Dunnett (1990)
Eagger SA, Levy R, Sahakian BJ (1991) Tacrine in Alzeimer's disease. Lancet 337:989–992 (10.1016/0140-6736(91)92656-M) / Lancet by SA Eagger (1991)
Grady S, Marks MJ, Wonnacott S, Collins AC (1992) Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848–856 (10.1111/j.1471-4159.1992.tb08322.x) / J Neurochem by S Grady (1992)
Hagan JJ, Morris RGM (1988) The cholinergic hypothesis of memory: a review of animal experiments. In: Iversen LL, Iversen SD, Snyder SH (eds) Psychopharmacology of the aging nervous system (Handbook of psychopharmacology, vol 20). Plenum, New York, pp 237–323 / Psychopharmacology of the aging nervous system (Handbook of psychopharmacology, vol 20) by JJ Hagan (1988)
Hodges H, Allen Y, Sinden J, Lantos PL, Gray JA (1991) Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system-II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced functional recovery. Neuroscience 45:609–623 (10.1016/0306-4522(91)90274-R) / Neuroscience by H Hodges (1991)
Hodges H, Sinden J, Turner JJ, Netto CA, Sowinski P, Gray JA (1992) Nicotine as a tool to characterise the role of forebrain cholinergic projection system in cognition. In: Lipiello PM, Collins AC, Gray JA, Robinson JH (eds) The biology of nicotine. Raven, New York, pp 157–180 / The biology of nicotine by H Hodges (1992)
Koelle GB (1975) Anticholinesterase agents. In: Goodman LS, Gillman AG (eds) The pharmacological basis of therapeutics, McMillan, New York, pp 445–466 / The pharmacological basis of therapeutics by GB Koelle (1975)
Lapchak PA, Araujo DM, Quirion R, Collier B (1989) Effects of chronic nicotine treatment on nicotine autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain. J Neurochem 52:483–491 (10.1111/j.1471-4159.1989.tb09146.x) / J Neurochem by PA Lapchak (1989)
Levin ED (1992) Nicotine systems and cognitive function. Psychopharmacology 108:417–431 (10.1007/BF02247415) / Psychopharmacology by ED Levin (1992)
Loullis CC, Dean RL, Lippa AS, Meyerson LR, Beer B, Bartus RT (1983) Chronic administration of cholinergic agents: effects on behaviour and calmodulin. Pharmacol Biochem Behav 18:601–604 (10.1016/0091-3057(83)90287-3) / Pharmacol Biochem Behav by CC Loullis (1983)
Mereu G, Yoon KW, Boi V, Gessa GL, Naes L, Westfall TC (1987) Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 141:395–399 (10.1016/0014-2999(87)90556-5) / Eur J Pharmacol by G Mereu (1987)
Nilsson-Håkansson L, Lai Z, Nordberg A (1990) Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain. Eur J Pharmacol 186:301–305 (10.1016/0014-2999(90)90448-F) / Eur J Pharmacol by L Nilsson-Håkansson (1990)
Rowell PP, Wonnacott S (1990) Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J Neurochem 55:2105–2110 (10.1111/j.1471-4159.1990.tb05802.x) / J Neurochem by PP Rowell (1990)
Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. Br J Psychiatry 154:797–800 (10.1192/bjp.154.6.797) / Br J Psychiatry by B Sahakian (1989)
Sandor NT, Zelles T, Kiss J, Sershen H, Torocsik A, Lajtha A, Vizi ES (1991) Effect of nicotine on dopaminergic-cholinergic interaction in the striatum. Brain Res 567:313–316 (10.1016/0006-8993(91)90810-I) / Brain Res by NT Sandor (1991)
Schiller GD (1979) Reduced binding of (3H]-quinuclidinyl benzilate associated with chronically low acetylcholinesterase activity. Life Sci 24:1159–1164 (10.1016/0024-3205(79)90052-3) / Life Sci by GD Schiller (1979)
Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220:214–216 (10.1126/science.6828889) / Science by RD Schwartz (1983)
Smith KM, Mitchell SN, Joseph MH (1991) Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J Neurochem 57:1750–1756 (10.1111/j.1471-4159.1991.tb06377.x) / J Neurochem by KM Smith (1991)
Stern Y, Sano M, Mayeux R (1987) Effects of oral physostigmine in Alzheimer's disease. Ann Neurol 22:306–310 (10.1002/ana.410220305) / Ann Neurol by Y Stern (1987)
Summers W, Majovski L, Marsh G, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long term treatment of senile dementia, Alzheimer type. N Engl J Med 315:239–245 (10.1056/NEJM198611133152001) / N Engl J Med by W Summers (1986)
Sunderland T, Tariot P, Mueller E, Murphy D, Weingartner H, Cohen R (1985) Pharmacological challenge strategies in Alzheimer's disease: basic and clinical issues. Psychopharmacol Bull 21:676–679 / Psychopharmacol Bull by T Sunderland (1985)
Werner G, Schmidt KH (1968) Chemische Analyse des Stoffwechsels von (−)-Scopolamin bei einigen Säugetieren. Hoppe-Seyler's Z Physiol Chem Bd 349:741–752 (10.1515/bchm2.1968.349.1.741) / Hoppe-Seyler's Z Physiol Chem Bd by G Werner (1968)

Dates

Type	When
Created	19 years, 9 months ago (Nov. 22, 2005, 4:48 p.m.)
Deposited	6 years, 3 months ago (May 16, 2019, 10:52 a.m.)
Indexed	1 year, 4 months ago (April 22, 2024, 9:55 a.m.)
Issued	32 years, 2 months ago (July 1, 1993)
Published	32 years, 2 months ago (July 1, 1993)
Published Print	32 years, 2 months ago (July 1, 1993)

Funders 0

None

BibTeX

@article{Abdulla_1993, title={Chronic treatments with cholinoceptor drugs influence spatial learning in rats}, volume={111}, ISSN={1432-2072}, url={http://dx.doi.org/10.1007/bf02253544}, DOI={10.1007/bf02253544}, number={4}, journal={Psychopharmacology}, publisher={Springer Science and Business Media LLC}, author={Abdulla, F. A. and Calaminici, M. -R. and Stephenson, J. D. and Sinden, J. D.}, year={1993}, month=jul, pages={508–511} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2024,
        4,
        22
      ]
    ],
    "date-time": "2024-04-22T13:55:27Z",
    "timestamp": 1713794127755
  },
  "reference-count": 30,
  "publisher": "Springer Science and Business Media LLC",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            1993,
            7,
            1
          ]
        ],
        "date-time": "1993-07-01T00:00:00Z",
        "timestamp": 741484800000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "http://www.springer.com/tdm"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        1993,
        7
      ]
    ]
  },
  "DOI": "10.1007/bf02253544",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2005,
        11,
        22
      ]
    ],
    "date-time": "2005-11-22T21:48:21Z",
    "timestamp": 1132696101000
  },
  "page": "508-511",
  "source": "Crossref",
  "is-referenced-by-count": 30,
  "title": "Chronic treatments with cholinoceptor drugs influence spatial learning in rats",
  "prefix": "10.1007",
  "volume": "111",
  "author": [
    {
      "given": "F. A.",
      "family": "Abdulla",
      "sequence": "first",
      "affiliation": []
    },
    {
      "given": "M. -R.",
      "family": "Calaminici",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "J. D.",
      "family": "Stephenson",
      "sequence": "additional",
      "affiliation": []
    },
    {
      "given": "J. D.",
      "family": "Sinden",
      "sequence": "additional",
      "affiliation": []
    }
  ],
  "member": "297",
  "reference": [
    {
      "key": "BF02253544_CR1",
      "unstructured": "Abdulla FA, Calaminici M-R, Gray JA, Sinden JD, Stephenson JD (1992) Chronic hyoscine and oxotremorine treatment alter the sensitivity of rat frontal cortex pyramidal cells to acetylcholine and carbachol. Br J Pharmacol 106:39P"
    },
    {
      "key": "BF02253544_CR2",
      "doi-asserted-by": "crossref",
      "first-page": "196",
      "DOI": "10.1016/S0163-1047(86)90772-7",
      "volume": "45",
      "author": "W Beatty",
      "year": "1986",
      "unstructured": "Beatty W, Butters N, Janowsky D (1986) Memory failure after scopolamine treatment: implications for cholinergic hypothesis of dementia. Behav Neural Biol 45:196\u2013211",
      "journal-title": "Behav Neural Biol"
    },
    {
      "key": "BF02253544_CR3",
      "doi-asserted-by": "crossref",
      "first-page": "163",
      "DOI": "10.1002/ddr.430120302",
      "volume": "12",
      "author": "RE Becker",
      "year": "1988",
      "unstructured": "Becker RE, Giacobini E (1988) Mechanisms of cholinesterase inhibition in senile dementia of Alzheimer type: clinical, pharmacological and therapeutic aspects. Drug Dev Res 12:163\u2013195",
      "journal-title": "Drug Dev Res"
    },
    {
      "key": "BF02253544_CR4",
      "doi-asserted-by": "crossref",
      "first-page": "73",
      "DOI": "10.1016/0014-2999(81)90325-3",
      "volume": "74",
      "author": "J Ben-Barak",
      "year": "1981",
      "unstructured": "Ben-Barak J, Gazit H, Silman I, Dudai Y (1981) In vivo modulation of the number of muscarinic receptors in rat brain by cholinergic ligands. Eur J Pharmacol 74:73\u201381",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02253544_CR5",
      "doi-asserted-by": "crossref",
      "first-page": "823",
      "DOI": "10.1016/0028-3908(91)90116-S",
      "volume": "30",
      "author": "MP Brazell",
      "year": "1990",
      "unstructured": "Brazell MP, Mitchell SN, Gray JA (1990) Effect of acute administration of nicotine on in vivo release of noradrenaline in the hippocampus of freely moving rats: a dose-response and antagonist study. Neuropharmacology 30:823\u2013833",
      "journal-title": "Neuropharmacology"
    },
    {
      "key": "BF02253544_CR6",
      "doi-asserted-by": "crossref",
      "first-page": "476",
      "DOI": "10.1037/0735-7044.100.4.476",
      "volume": "100",
      "author": "O Bure\u0161ova",
      "year": "1986",
      "unstructured": "Bure\u0161ova O, Bolthius J, Bure\u0161 J (1986) Differential effects of cholinergic blockade on performance of rats in the water tank navigation task and in a radial arm maze. Behav Neuroscience 100:476\u2013482",
      "journal-title": "Behav Neuroscience"
    },
    {
      "key": "BF02253544_CR7",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/0306-4522(86)90002-3",
      "volume": "19",
      "author": "D Collerton",
      "year": "1986",
      "unstructured": "Collerton D (1986) Cholinergic function and intellectual decline in Alzheimer's disease. Neuroscience 19:1\u201328",
      "journal-title": "Neuroscience"
    },
    {
      "key": "BF02253544_CR8",
      "doi-asserted-by": "crossref",
      "first-page": "357",
      "DOI": "10.1146/annurev.pa.21.040181.002041",
      "volume": "21",
      "author": "I Creese",
      "year": "1981",
      "unstructured": "Creese I, Sibley DR (1981) Receptor adaptations to centrally acting drugs. Annu Rev Pharmacol Toxicol 21:357\u2013391",
      "journal-title": "Annu Rev Pharmacol Toxicol"
    },
    {
      "key": "BF02253544_CR9",
      "doi-asserted-by": "crossref",
      "first-page": "567",
      "DOI": "10.1111/j.1460-9568.1990.tb00448.x",
      "volume": "2",
      "author": "SB Dunnett",
      "year": "1990",
      "unstructured": "Dunnett SB (1990) Neural transplantation in animal models of dementia. Eur J Neurosci 2:567\u2013587",
      "journal-title": "Eur J Neurosci"
    },
    {
      "key": "BF02253544_CR10",
      "doi-asserted-by": "crossref",
      "first-page": "989",
      "DOI": "10.1016/0140-6736(91)92656-M",
      "volume": "337",
      "author": "SA Eagger",
      "year": "1991",
      "unstructured": "Eagger SA, Levy R, Sahakian BJ (1991) Tacrine in Alzeimer's disease. Lancet 337:989\u2013992",
      "journal-title": "Lancet"
    },
    {
      "key": "BF02253544_CR11",
      "doi-asserted-by": "crossref",
      "first-page": "848",
      "DOI": "10.1111/j.1471-4159.1992.tb08322.x",
      "volume": "59",
      "author": "S Grady",
      "year": "1992",
      "unstructured": "Grady S, Marks MJ, Wonnacott S, Collins AC (1992) Characterization of nicotinic receptor-mediated [3H]dopamine release from synaptosomes prepared from mouse striatum. J Neurochem 59:848\u2013856",
      "journal-title": "J Neurochem"
    },
    {
      "key": "BF02253544_CR12",
      "first-page": "237",
      "volume-title": "Psychopharmacology of the aging nervous system (Handbook of psychopharmacology, vol 20)",
      "author": "JJ Hagan",
      "year": "1988",
      "unstructured": "Hagan JJ, Morris RGM (1988) The cholinergic hypothesis of memory: a review of animal experiments. In: Iversen LL, Iversen SD, Snyder SH (eds) Psychopharmacology of the aging nervous system (Handbook of psychopharmacology, vol 20). Plenum, New York, pp 237\u2013323"
    },
    {
      "key": "BF02253544_CR13",
      "doi-asserted-by": "crossref",
      "first-page": "609",
      "DOI": "10.1016/0306-4522(91)90274-R",
      "volume": "45",
      "author": "H Hodges",
      "year": "1991",
      "unstructured": "Hodges H, Allen Y, Sinden J, Lantos PL, Gray JA (1991) Effects of cholinergic-rich neural grafts on radial maze performance of rats after excitotoxic lesions of the forebrain cholinergic projection system-II. Cholinergic drugs as probes to investigate lesion-induced deficits and transplant-induced functional recovery. Neuroscience 45:609\u2013623",
      "journal-title": "Neuroscience"
    },
    {
      "key": "BF02253544_CR14",
      "first-page": "157",
      "volume-title": "The biology of nicotine",
      "author": "H Hodges",
      "year": "1992",
      "unstructured": "Hodges H, Sinden J, Turner JJ, Netto CA, Sowinski P, Gray JA (1992) Nicotine as a tool to characterise the role of forebrain cholinergic projection system in cognition. In: Lipiello PM, Collins AC, Gray JA, Robinson JH (eds) The biology of nicotine. Raven, New York, pp 157\u2013180"
    },
    {
      "key": "BF02253544_CR15",
      "first-page": "445",
      "volume-title": "The pharmacological basis of therapeutics",
      "author": "GB Koelle",
      "year": "1975",
      "unstructured": "Koelle GB (1975) Anticholinesterase agents. In: Goodman LS, Gillman AG (eds) The pharmacological basis of therapeutics, McMillan, New York, pp 445\u2013466"
    },
    {
      "key": "BF02253544_CR16",
      "doi-asserted-by": "crossref",
      "first-page": "483",
      "DOI": "10.1111/j.1471-4159.1989.tb09146.x",
      "volume": "52",
      "author": "PA Lapchak",
      "year": "1989",
      "unstructured": "Lapchak PA, Araujo DM, Quirion R, Collier B (1989) Effects of chronic nicotine treatment on nicotine autoreceptor function and N-[3H]methylcarbamylcholine binding sites in the rat brain. J Neurochem 52:483\u2013491",
      "journal-title": "J Neurochem"
    },
    {
      "key": "BF02253544_CR17",
      "doi-asserted-by": "crossref",
      "first-page": "417",
      "DOI": "10.1007/BF02247415",
      "volume": "108",
      "author": "ED Levin",
      "year": "1992",
      "unstructured": "Levin ED (1992) Nicotine systems and cognitive function. Psychopharmacology 108:417\u2013431",
      "journal-title": "Psychopharmacology"
    },
    {
      "key": "BF02253544_CR18",
      "doi-asserted-by": "crossref",
      "first-page": "601",
      "DOI": "10.1016/0091-3057(83)90287-3",
      "volume": "18",
      "author": "CC Loullis",
      "year": "1983",
      "unstructured": "Loullis CC, Dean RL, Lippa AS, Meyerson LR, Beer B, Bartus RT (1983) Chronic administration of cholinergic agents: effects on behaviour and calmodulin. Pharmacol Biochem Behav 18:601\u2013604",
      "journal-title": "Pharmacol Biochem Behav"
    },
    {
      "key": "BF02253544_CR19",
      "doi-asserted-by": "crossref",
      "first-page": "395",
      "DOI": "10.1016/0014-2999(87)90556-5",
      "volume": "141",
      "author": "G Mereu",
      "year": "1987",
      "unstructured": "Mereu G, Yoon KW, Boi V, Gessa GL, Naes L, Westfall TC (1987) Preferential stimulation of ventral tegmental area dopaminergic neurons by nicotine. Eur J Pharmacol 141:395\u2013399",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02253544_CR20",
      "doi-asserted-by": "crossref",
      "first-page": "301",
      "DOI": "10.1016/0014-2999(90)90448-F",
      "volume": "186",
      "author": "L Nilsson-H\u00e5kansson",
      "year": "1990",
      "unstructured": "Nilsson-H\u00e5kansson L, Lai Z, Nordberg A (1990) Tetrahydroaminoacridine induces opposite changes in muscarinic and nicotinic receptors in rat brain. Eur J Pharmacol 186:301\u2013305",
      "journal-title": "Eur J Pharmacol"
    },
    {
      "key": "BF02253544_CR21",
      "doi-asserted-by": "crossref",
      "first-page": "2105",
      "DOI": "10.1111/j.1471-4159.1990.tb05802.x",
      "volume": "55",
      "author": "PP Rowell",
      "year": "1990",
      "unstructured": "Rowell PP, Wonnacott S (1990) Evidence for functional activity of up-regulated nicotine binding sites in rat striatal synaptosomes. J Neurochem 55:2105\u20132110",
      "journal-title": "J Neurochem"
    },
    {
      "key": "BF02253544_CR22",
      "doi-asserted-by": "crossref",
      "first-page": "797",
      "DOI": "10.1192/bjp.154.6.797",
      "volume": "154",
      "author": "B Sahakian",
      "year": "1989",
      "unstructured": "Sahakian B, Jones G, Levy R, Gray J, Warburton D (1989) The effects of nicotine on attention, information processing, and short-term memory in patients with dementia of Alzheimer type. Br J Psychiatry 154:797\u2013800",
      "journal-title": "Br J Psychiatry"
    },
    {
      "key": "BF02253544_CR23",
      "doi-asserted-by": "crossref",
      "first-page": "313",
      "DOI": "10.1016/0006-8993(91)90810-I",
      "volume": "567",
      "author": "NT Sandor",
      "year": "1991",
      "unstructured": "Sandor NT, Zelles T, Kiss J, Sershen H, Torocsik A, Lajtha A, Vizi ES (1991) Effect of nicotine on dopaminergic-cholinergic interaction in the striatum. Brain Res 567:313\u2013316",
      "journal-title": "Brain Res"
    },
    {
      "key": "BF02253544_CR24",
      "doi-asserted-by": "crossref",
      "first-page": "1159",
      "DOI": "10.1016/0024-3205(79)90052-3",
      "volume": "24",
      "author": "GD Schiller",
      "year": "1979",
      "unstructured": "Schiller GD (1979) Reduced binding of (3H]-quinuclidinyl benzilate associated with chronically low acetylcholinesterase activity. Life Sci 24:1159\u20131164",
      "journal-title": "Life Sci"
    },
    {
      "key": "BF02253544_CR25",
      "doi-asserted-by": "crossref",
      "first-page": "214",
      "DOI": "10.1126/science.6828889",
      "volume": "220",
      "author": "RD Schwartz",
      "year": "1983",
      "unstructured": "Schwartz RD, Kellar KJ (1983) Nicotinic cholinergic receptor binding sites in the brain: regulation in vivo. Science 220:214\u2013216",
      "journal-title": "Science"
    },
    {
      "key": "BF02253544_CR26",
      "doi-asserted-by": "crossref",
      "first-page": "1750",
      "DOI": "10.1111/j.1471-4159.1991.tb06377.x",
      "volume": "57",
      "author": "KM Smith",
      "year": "1991",
      "unstructured": "Smith KM, Mitchell SN, Joseph MH (1991) Effects of chronic and subchronic nicotine on tyrosine hydroxylase activity in noradrenergic and dopaminergic neurones in the rat brain. J Neurochem 57:1750\u20131756",
      "journal-title": "J Neurochem"
    },
    {
      "key": "BF02253544_CR27",
      "doi-asserted-by": "crossref",
      "first-page": "306",
      "DOI": "10.1002/ana.410220305",
      "volume": "22",
      "author": "Y Stern",
      "year": "1987",
      "unstructured": "Stern Y, Sano M, Mayeux R (1987) Effects of oral physostigmine in Alzheimer's disease. Ann Neurol 22:306\u2013310",
      "journal-title": "Ann Neurol"
    },
    {
      "key": "BF02253544_CR28",
      "doi-asserted-by": "crossref",
      "first-page": "239",
      "DOI": "10.1056/NEJM198611133152001",
      "volume": "315",
      "author": "W Summers",
      "year": "1986",
      "unstructured": "Summers W, Majovski L, Marsh G, Tachiki K, Kling A (1986) Oral tetrahydroaminoacridine in long term treatment of senile dementia, Alzheimer type. N Engl J Med 315:239\u2013245",
      "journal-title": "N Engl J Med"
    },
    {
      "key": "BF02253544_CR29",
      "first-page": "676",
      "volume": "21",
      "author": "T Sunderland",
      "year": "1985",
      "unstructured": "Sunderland T, Tariot P, Mueller E, Murphy D, Weingartner H, Cohen R (1985) Pharmacological challenge strategies in Alzheimer's disease: basic and clinical issues. Psychopharmacol Bull 21:676\u2013679",
      "journal-title": "Psychopharmacol Bull"
    },
    {
      "key": "BF02253544_CR30",
      "doi-asserted-by": "crossref",
      "first-page": "741",
      "DOI": "10.1515/bchm2.1968.349.1.741",
      "volume": "349",
      "author": "G Werner",
      "year": "1968",
      "unstructured": "Werner G, Schmidt KH (1968) Chemische Analyse des Stoffwechsels von (\u2212)-Scopolamin bei einigen S\u00e4ugetieren. Hoppe-Seyler's Z Physiol Chem Bd 349:741\u2013752",
      "journal-title": "Hoppe-Seyler's Z Physiol Chem Bd"
    }
  ],
  "container-title": "Psychopharmacology",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF02253544.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/article/10.1007/BF02253544/fulltext.html",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://link.springer.com/content/pdf/10.1007/BF02253544",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2019,
        5,
        16
      ]
    ],
    "date-time": "2019-05-16T14:52:26Z",
    "timestamp": 1558018346000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "http://link.springer.com/10.1007/BF02253544"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        1993,
        7
      ]
    ]
  },
  "references-count": 30,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          1993,
          7
        ]
      ]
    }
  },
  "alternative-id": [
    "BF02253544"
  ],
  "URL": "http://dx.doi.org/10.1007/BF02253544",
  "relation": {},
  "ISSN": [
    "0033-3158",
    "1432-2072"
  ],
  "subject": [],
  "container-title-short": "Psychopharmacology",
  "published": {
    "date-parts": [
      [
        1993,
        7
      ]
    ]
  }
}